Perspectives and Experiences of Health Care Professionals and Patients with Diabetes regarding Self-Monitoring of Blood Glucose in Canada

2010 ◽  
Vol 143 (5) ◽  
pp. 218-225 ◽  
Author(s):  
Brendan McIntosh ◽  
Bernard Gauthier ◽  
Avtar Lal ◽  
Sumeet R. Singh ◽  
Adil Virani
Keyword(s):  
Health Care ◽  
Blood Glucose ◽  
Health Care Professionals ◽  
Self Monitoring ◽  
Patients With Diabetes

scholarly journals Prevalence of Different Types of Barriers to the Use of Glucometer in Diabetic Patients

2021 ◽  
Vol 11 (9) ◽  
pp. 181-186
Author(s):  
Abhishek Pradha ◽  
Charutha Reji ◽  
A. R. Shabaraya
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Health Care Professionals ◽  
Diabetic Patients ◽  
Self Monitoring ◽  
Different Types ◽  
Patients With Diabetes ◽  
Complexity Cost ◽  
The Cost ◽  
Lack Of Knowledge

Self-monitoring of blood glucose (SMBG) is a very useful method for patients with diabetes to maintain glycaemic control. Different types of barriers in glucometer use of diabetic patients include the high cost of strips, pain, lack of knowledge and motivation, need of assistance and lack of inventory supplies of glucometer. The purpose of the study was to access the prevalence of different types of barriers to the use of glucometer in diabetic patients. A prospective observational study involving 150 diabetic patients was conducted at a Dakshina Kannada from January 2021 to June 2021. The study was conducted among patients of both gender having Type 1 and Type 2 Diabetes mellitus. A total of 150 patients participated in our study qualifying the inclusion criteria. The main factors influencing the glucometer use was related to its cost, pain, lack of knowledge and supply. The barriers found were mainly the cost of the strips, fear for needles, pain, lack of knowledge and motivation, need of assistance and lack of inventory supplies of glucometer. Participants insight to the purpose of glucometer use, complexity, cost, pain related to glucometer as well as educating, catering knowledge and motivation were the key factors taken care by the health care professionals while advising the patients having diabetes mellitus with SMBG. Key words: Self-monitoring blood glucose level (SMBG), Diabetes mellitus (DM).

Glukosemessung

2019 ◽  
Vol 17 (07) ◽  
pp. 258-260
Author(s):  
Elisabeth Schnellbächer
Keyword(s):  
Health Care ◽  
Blood Glucose ◽  
Health Care Professionals ◽  
Self Monitoring

Fünf Jahre nach der Erstauflage des „Leitfaden zur Blutglukose-Selbstkontrolle in Beratung und Therapie“ durch den Verband der Diabetes-Beratungs- und Schulungsberufe e. V. (VDBD e. V.) ist die aktualisierte Fassung im Mai 2019 erschienen. Sie trägt den Titel: „Leitfaden zur Glukose-Selbstkontrolle in Beratung und Therapie“. Im ersten Leitfaden wurde ausschließlich die Selbstmessung der Blutglukose (self monitoring of blood glucose; SMBG) durch Betroffene und deren Angehörige thematisiert. Adressaten des Leitfadens waren Health Care Professionals, die in ihrer täglichen Beratungspraxis unterstützt werden sollten.

Self-monitoring of blood glucose and perceived obstacles in Turkish patients with diabetes mellitus

2014 ◽  
Author(s):  
Ozlem Turhan Iyidir ◽  
Mustafa Unubol ◽  
Bulent Ogun Hatipoglu ◽  
Ceyla Konca Degertekin
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Self Monitoring ◽  
Patients With Diabetes ◽  
Turkish Patients

Digital Diabetes Care System Observations from a market acceptance evaluation study in Vietnam (Preprint)

2019 ◽  
Author(s):  
Tran Quang Khanh ◽  
Pham Nhu Hao ◽  
Eytan Roitman ◽  
Baruch Marganitt ◽  
Avivit Cahn
Keyword(s):  
Health Care ◽  
Blood Glucose ◽  
Health Care Professional ◽  
Diabetes Care ◽  
Health Care Professionals ◽  
Mobile App ◽  
Physician Satisfaction ◽  
Diabetes Clinic ◽  
Blood Glucose Monitor ◽  
Hba1c Levels

BACKGROUND Digital technologies are gaining an important role in the management of patients with diabetes. The GlucoMe solution integrates multiple aspects of diabetes care: 1) Wireless blood glucose monitor - communicates glucose data automatically to any smartphone; 2) Mobile-app - securely transmits real-time blood glucose monitor data for cloud based analyses, and enables 2-way communication between patients and health care professionals; 3) Digital diabetes clinic – analyzes and presents data to the health care professional; and 4) Control tower software provides population management reports and sends individualized alerts. OBJECTIVE Assess clinical outcomes and user satisfaction of incorporating the GlucoMe digital solution in diabetes clinics of a developing country. METHODS Five hospital endocrinology clinics in Vietnam participated in a market acceptance evaluation pilot of the GlucoMe system. The clinics sequentially recruited all patients willing to join, so long as they had a smartphone and access to internet connectivity. Patients were provided with the GlucoMe app and blood glucose monitor and instructed in their use in individual or groups sessions. The digital diabetes clinic and control tower software were installed in the clinic computers. Face-to-face visits were conducted at baseline and at 12 weeks, with monthly digital visits scheduled in the interim and additional digital visits performed as needed. HbA1c levels were measured at baseline and at 12 weeks (±20 days). Treatment modification was at the discretion of the treating physician. Outcome measures included adherence to glucose monitoring, change in glycemic parameters and patient and physician satisfaction as assessed by questionnaires. Only patients completing the pilot were included in data analyses. RESULTS The study recruited 300 patients of whom 279 patients completed the evaluation. Dropout was due to change in internet access availability (18) or death (3). Adherence to glucose measurements gradually declined, yet, at study end 81% of the patients were measuring glucose at least once a week. Digital contact from the health care professional to the patient or vice-versa (excluding automated alerts) occurred in average every 6.2 days. Average glucose levels declined from 170.4±64.6 mg/dl in the first two weeks to 150.8±53.2 mg/dl in the last two weeks (P<0.001) (n=221). HbA1c levels at baseline and 12 weeks were available for only 126 of the patients and declined from 8.3±1.9% to 7.6±1.3 (P<0.001). Over 95% of the physicians and patients stated they would strongly support the broad usage of the GlucoMe platform in diabetes clinics across the country. CONCLUSIONS The GlucoMe digital solution was broadly accepted by both patients and health care professionals and improved glycemic outcomes. The digital platform yielded increased number of patient-health care professional interactions, yet of short duration, enabling judicious allocation of limited time resources. The durability, scalability and cost-effectiveness of this approach merit further study.

scholarly journals Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period

Medicina ◽  
2021 ◽  
Vol 57 (2) ◽  
pp. 167
Author(s):  
Gyorgy Jermendy ◽  
Agnes Kecskes ◽  
Attila Nagy
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Significant Risk ◽  
Clinical Importance ◽  
Capillary Blood ◽  
Nocturnal Hypoglycaemia ◽  
Capillary Blood Glucose ◽  
Self Monitoring ◽  
Support Materials ◽  
Patients With Diabetes

Background and Objectives: In patients with diabetes mellitus, hypoglycaemic episodes, especially during night hours, carry a significant risk. Data about the occurrence of nocturnal hypoglycaemia in real-world settings are of clinical importance. The aim of our study was to evaluate the occurrence of nocturnal hypoglycaemia among patients with diabetes using self-monitoring of blood glucose (SMBG) with telemedicine support. Materials and Methods: We retrospectively analysed the central database of an internet-based supportive system between 2010 and 2020 when 8190 SMBG users uploaded nearly 10 million capillary blood glucose values. Nocturnal hypoglycaemia was defined as capillary blood glucose < 3.0 mmol/L measured between 00:00 and 05:59 h. Results: The database contained 914,146 nocturnal blood glucose values from 7298 users; 24,623 (2.7%) glucose values were below the hypoglycaemic threshold and 2363 patients (32.4%) had at least one hypoglycaemic glucose value. Nocturnal hypoglycaemia was more often found in patients with type 1 vs. type 2 diabetes (n = 1890 (80.0%) vs. n = 387 (16.4%), respectively). Hypoglycaemic blood glucose values were most frequently observed in the age group of 10.0–19.9 years (n = 481 (20.4%)). Patients with nocturnal hypoglycaemia were mostly on insulin treatment (1854 (78.5%) patients with 20,727 (84.1%) hypoglycaemic glucose values). Only 356 patients (15.1%) with nocturnal hypoglycaemia performed a retest within 120 min. Within a one-day-long (1440 min) timeframe, the elapsed median time until a retest, yielding a safe blood glucose value (>3.9 mml/L), was 273 min (interquartile range: 157–300 min). Conclusions: Nocturnal hypoglycaemia should be considered as a persisting challenge to antihyperglycaemic treatment in patients living with diabetes. Continuous efforts are needed to improve both antihyperglycaemic treatment and patient education for preventing nocturnal hypoglycaemia, and to act adequately if hypoglycaemic values are detected.

scholarly journals Self-monitoring of blood glucose in patients with diabetes who do not use insulin-are guidelines evidence-based?

2012 ◽  
Vol 29 (10) ◽  
pp. 1226-1236 ◽  
Author(s):  
K. M. Aakre ◽  
J. Watine ◽  
P. S. Bunting ◽  
S. Sandberg ◽  
W. P. Oosterhuis
Keyword(s):  
Blood Glucose ◽  
Evidence Based ◽  
Self Monitoring ◽  
Patients With Diabetes
Sign in / Sign up

Export Citation Format

Share Document